At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 103 enrolled
Drug / intervention
Midazolam +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Different Sedation Regimes Administered by Anesthesiologists or Endoscopists on Cognitive Functions in Lower Gastrointestinal System Endoscopy
In Brief
A Phase 4 clinical trial evaluating Midazolam, Meperidine, and 2 other interventions for Gastrointestinal Dysfunction and Alteration of Cognitive Function. Completed, enrolled 103 participants.
Detailed Summary
There are different sedation regimes for lower gastrointestinal system endoscopy which can be administered by anesthesiologists and non-anesthesiologists. This study aims to compare the effects of propofol/remifentanil combination and midazolam/meperidine combination on early cognitive function following lower gastrointestinal system endoscopies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
Primary CompletionJun 2015
First PostedJul 2015
TodayJul 2026
First PostedJul 1, 2015
Enrollment StartMay 1, 2015
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.0 years ago
Interventions
Midazolamdrug
Dosage adjustment
Meperidinedrug
Dosage adjustment
Remifentanildrug
Dosage adjustment
Propofoldrug
Dosage adjustment